It is likely that in an ERα-positive breast carcinoma with aberrant expression of Smad4, TGF-β not only is unable to inhibit tumor growth, but also promote tumor progression through enhancing the estrogen-ERα mediated cell proliferation. Here, TGFB1 is linked to breast carcinoma.